Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site

Catherine L Sheppard1, Louisa C Y Lee1, Elaine V Hill1

  • 1Institute of Neuroscience and Psychology, Wolfson Link and Davidson Buildings, University of Glasgow, University Avenue, Glasgow G12 8QQ, Scotland, UK.

Cellular Signalling
|May 13, 2014
PubMed

Insights

During mitosis, phosphodiesterase-4D9 (PDE4D9) activity increases, degrading cyclic AMP (cAMP) and reducing protein kinase A (PKA) activity. PDE4D9 activation regulates cell cycle progression in Rat-1 cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitosis is characterized by decreased intracellular cyclic adenosine monophosphate (cAMP) and cAMP-activated protein kinase A (PKA) activity.
  • This decrease is paralleled by increased activity of cAMP-hydrolyzing phosphodiesterase-4 (PDE4).

Purpose of the Study:

  • To investigate the role of PDE4 in regulating cAMP and PKA levels during mitosis.
  • To identify the specific PDE4 isoform responsible for mitotic PDE4 activity and its regulatory mechanisms.

Main Methods:

  • Using Rat-1 cells and selective PDE inhibitors (rolipram for PDE4, cilostamide for PDE3).
  • Employing selective immunopurification to identify PDE4 sub-families.
  • Analyzing PDE4D9 phosphorylation sites and localization using techniques like SDS-PAGE and microscopy.

Main Results:

  • PDE4 activation, not PDE3, underlies the reduction in PKA activity during mitosis.
  • PDE4 inhibition accelerates cell cycle transit through G2/M and prolongs G1 phase.
  • PDE4D9 is the sole PDE4 isoform activated during mitosis, undergoing multi-site phosphorylation by ERK, a switch kinase, MK2, and AMPK.
  • PDE4D9 is localized to the perinuclear region and cell margins.

Conclusions:

  • Mitotic decrease in cAMP and PKA activity is mediated by enhanced cAMP degradation by PDE4D9.
  • Multi-site phosphorylation regulates PDE4D9 activation during mitosis.
  • PDE4D9 localization and regulation are critical for controlling cell cycle dynamics.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...